Tennessee Valley Cooperative Human Tissue Network
Tennessee Valley Cooperative Human Tissue Network
批准号:
10577781
负责人:
MARY Kay WASHINGTON
金额:
$86.11万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2024-03-31
关键词:
Academic Medical CentersAchievementAdherenceAdultAdvocacyAwarenessBasic ScienceBiologicalBiomedical ResearchBusinessesCaringCellsClinicalClinical DataCollectionCommunicationCommunitiesComplexComputer softwareConfidentiality of Patient InformationCooperative Human Tissue NetworkData SetDevelopmentDiseaseDisparity populationEducationEnsureEthicsFeedbackFundingGoalsHumanIndustry StandardInformaticsInfrastructureInternationalLeadershipLinkMalignant NeoplasmsMarketingModelingModernizationPatientsPerformancePlayProcessProductivityPublic HealthQualifyingQuality ControlRare LesionRegulationResearchResearch PersonnelRoleScienceSecurityServicesSiteSocietiesSolidSourceSpecimenSuspensionsSystemTechnologyTennesseeThinnessTissue SampleTissuesTranslational ResearchTumor-Infiltrating Lymphocytesbiobankcost effectivedesignexperiencehuman diseasehuman subject protectionhuman tissueimprovedindividual patientinnovationmemberneoplasticnetwork informaticsnoveloperationpatient engagementprogramsprospectiverepositoryresponsesatisfactionsocial mediatumor progressionweb services
中文摘要
项目总结
自1987年以来,合作的人类组织网络(CHTN)作为一种来源发挥了重要作用
用于生物医学研究的人体组织。为此,西部师的首要目标是
范德比尔特大学医学中心(CHTN-VUMC)的CHTN将继续为
社区通过采购和分发成人生物标本,利用严格的质量管理
计划,以维持高效和多产的生物信息库操作。这一目标的关键方面
是临床上定制的高质量固体组织和生物液的预期集合
将严格的质量管理体系诠释和应用到项目的各个方面。
将通过发射另外两个卫星站点进行收集,从而扩大人口覆盖面。新的
单细胞悬液、分离肿瘤浸润性淋巴细胞和TMA等服务建立在
提出了针对不断变化的调查员需求的需求。此外,癌前病变和罕见癌
病变将被存入银行,以促进肿瘤进展的研究。CHTN-VUMC将坚持
严格的道德标准,保护人类受试者和患者的机密性,并将与
与VUMC倡导计划合作,以吸引患者并提供参与
研究。我们还建议作为信息学(IT)跨网络协调中心
负责“调查员IT”系统的第二个版本,利用网络服务和强大的
现代技术先进的平台,并确保遵守IT安全最佳实践。在ITS中
部门IT战略,CHTN-VUMC将开发和整合新的商业模式和新的
提高运营效率的信息学战略,包括与VUMC BioVu合作
将组织样本与大型临床数据集联系起来的项目。营销努力将包括以下举措:
提高科学界对CHTN的认识,包括加强使用社交媒体,以及
CHTN-VUMC将通过在以下领域的领导,为生物信息库科学和教育做出积极贡献
例如国际生物和环境储存库协会。
CHTN-VUMC在网络IT开发方面的领先地位使该部门成为唯一有资格担任
中央IT站点。标本分发的良好记录,有64,358个标本运往
过去6.5年的1011名调查人员,突出了现有CHTN-VUMC的能力
基础设施。CHTN-VUMC在下一个资金期的目标包括在这些基础上
在提高网络、调查人员和科学人员内部的效率和沟通方面取得的成就
社区。
英文摘要
PROJECT SUMMARY
The Cooperative Human Tissue Network (CHTN) has played an important role since 1987 as a source
for human tissues for biomedical research. To this end, the overarching goal of the Western Division of
the CHTN at Vanderbilt University Medical Center (CHTN-VUMC) is to continue to serve the scientific
community by procuring and distributing adult biospecimens, utilizing a stringent quality management
program to maintain a highly efficient and productive biorepository operation. Key aspects of this goal
are the prospective customized collection of high quality solid tissues and biofluids with clinical
annotation and application of a rigorous Quality Management System to all aspects of the program.
Demographic coverage will be expanded by launching two additional satellite sites for collection. New
services, such as single-cell suspensions, isolation of tumor infiltrating lymphocytes and TMA Build On
Demand in response to changing investigator needs are proposed. In addition preneoplastic and rare
lesions will be banked to facilitate research in tumor progression. The CHTN-VUMC will adhere to
rigorous ethical standards for protection of human subjects and patient confidentiality, and will partner
with the VUMC advocacy program to engage patients and provide opportunities for participation in
research. We also propose to serve as the Informatics (IT) trans-network Coordinating Center
responsible for the second version of the “Investigators IT” system, utilizing web services and a strong
modern technologically advanced platform and ensuring adherence to IT security best practices. In its
divisional IT strategy, CHTN-VUMC will develop and integrate new business models and novel
informatics strategies to improve operational efficiency, including partnering with the VUMC BioVu
project to link tissue samples to large clinical datasets. Marketing efforts will include initiatives to
increase awareness of CHTN in the scientific community, including enhanced use of social media, and
CHTN-VUMC will actively contribute to biorepository science and education through leadership in
societies such as the International Society for Biological and Environmental Repositories.
CHTN-VUMC's leadership in network IT development makes the division uniquely qualified to serve as
the central IT site. A robust track record of specimen distribution, with 64,358 specimens shipped to
1011 investigators over the past 6.5 years, highlights the capabilities of the existing CHTN-VUMC
infrastructure. CHTN-VUMC goals in the next funding period include building upon these foundational
achievements to improve efficiency and communication within the network, investigators and scientific
community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core 1: Tissue Pathology and Cellular Analysis
-
批准号:10218106
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2019
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Core 1: Tissue Pathology and Cellular Analysis
-
批准号:10443608
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2019
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Core 1: Tissue Pathology and Cellular Analysis
-
批准号:10700840
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2019
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Tennessee Valley Cooperative Human Tissue Network
-
批准号:9899210
-
项目类别:
-
资助金额:$91.28万
-
财政年份:2014
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Tennessee Valley Cooperative Human Tissue Network
-
批准号:9247707
-
项目类别:
-
资助金额:$98.9万
-
财政年份:2014
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Tennessee Valley Cooperative Human Tissue Network
-
批准号:10378774
-
项目类别:
-
资助金额:$86.84万
-
财政年份:2014
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Tennessee Valley Cooperative Human Tissue Network
-
批准号:8669436
-
项目类别:
-
资助金额:$98.12万
-
财政年份:2014
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Gastric Histopathology Core
-
批准号:8413060
-
项目类别:
-
资助金额:$18.54万
-
财政年份:2013
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Gastric Histopathology Core
-
批准号:8632354
-
项目类别:
-
资助金额:$17.4万
-
财政年份:2009
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Gastric Histopathology Core
-
批准号:8990359
-
项目类别:
-
资助金额:$4.82万
-
财政年份:2009
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Gastric Histopathology Core
-
批准号:7617408
-
项目类别:
-
资助金额:$20.56万
-
财政年份:2008
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Understanding and Controlling p120 Dysfunction in CRC
-
批准号:7245694
-
项目类别:
-
资助金额:$25.91万
-
财政年份:2007
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Tissue
-
批准号:7245710
-
项目类别:
-
资助金额:$14.48万
-
财政年份:2007
-
负责人:MARY Kay WASHINGTON
-
依托单位:
ARIOL SL-50 WORKSTATION & REVIEW STATIONS: WOUND HEALING & GASTROINTESTINAL DIS
-
批准号:7166660
-
项目类别:
-
资助金额:$6.76万
-
财政年份:2005
-
负责人:MARY Kay WASHINGTON
-
依托单位:
ARIOL SL-50 WORKSTATION AND REVIEW STATIONS: CELL BIOLOGY
-
批准号:7166661
-
项目类别:
-
资助金额:$5.07万
-
财政年份:2005
-
负责人:MARY Kay WASHINGTON
-
依托单位:
ARIOL SL-50 WORKSTATION : BREAST, COLORECTAL, GASTRIC, PROSTATE, & LUNG CANCER
-
批准号:7166659
-
项目类别:
-
资助金额:$21.96万
-
财政年份:2005
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Ariol SL-50 Workstation and Review Stations
-
批准号:6877240
-
项目类别:
-
资助金额:$33.79万
-
财政年份:2005
-
负责人:MARY Kay WASHINGTON
-
依托单位:
HUMAN TISSUE ACQUISITION & PATHOLOGY SHARED RESOURCES
-
批准号:6990165
-
项目类别:
-
资助金额:$12.81万
-
财政年份:2004
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Translational Pathology and Imaging
-
批准号:8343665
-
项目类别:
-
资助金额:$17.53万
-
财政年份:2002
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Preclinical Models of Digestive Diseases
-
批准号:8665900
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2002
-
负责人:MARY Kay WASHINGTON
-
依托单位:
海外基金